Selective targeting of cancer and senescence via shared metabolic shifts extends lifespan of old mice
{{output}}
Eliminating both senescent and cancer cells through pharmacological intervention presents a powerful therapeutic strategy against aging and tumor progression. Navitoclax has emerged as a promising candidate with both senolytic and antitumor activity, but its c... ...